Spago Nanomedical Interim Report January-September 2026
(PR-inside.com) LUND, SE / ACCESS Newswire / November 5, 2026 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) JULY - SEPTEMBER IN BRIEF Net sales for the quarter amounted to KSEK 0 (KSEK 14) The loss for the quarter amounted to KSEK -4,377 (KSEK -6,265) Operating expenses for the quarter amounted to KSEK -4,766 (KSEK -7,…
Short extract only — this publisher licenses its text. Read the full release at the source.
Free plan · Plus CA$29 or Pro CA$99/month


